Sort
261,768 grants matching “gene therapy”
Transgenic Models for Prostate and Breast Cancer
$2,222,881Jeffrey E Green · Basic Sciences · Z01 · FY2007 · CA
Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease
$2,222,688Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$2,222,489Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2010 · GM
Broad Institute Center for Cancer Systems Biology
$2,222,285Todd R. Golub · Broad Institute, Inc. · U54 · FY2010 · CA
Protection of Ischemic Myocardium
$2,222,251Roberto Bolli · University Of Louisville · P01 · FY2008 · HL
Bone Marrow Transplantation in Human Disease
$2,221,695Richard J Jones · Johns Hopkins University · P01 · FY2021 · CA
Bone Marrow Transplantation in Human Disease
$2,221,695Richard J Jones · Johns Hopkins University · P01 · FY2022 · CA
Bone Marrow Transplantation in Human Disease
$2,221,695Richard J Jones · Johns Hopkins University · P01 · FY2020 · CA
Costimulatory Mechanisms of Autoimmunity (Composite)
$2,220,927David A. Hafler · Yale University · P01 · FY2010 · AI
The Pacific Northwest Prostate Cancer SPORE
$2,220,357Peter S Nelson · Fred Hutchinson Cancer Research Center · P50 · FY2017 · CA
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$2,220,204Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$2,220,163John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
GENERAL CLINICAL RESEARCH CENTER
$2,220,087University Of Alabama At Birmingham · M01 · FY2000 · RR
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
$2,219,762James Douglas Engel · University Of Michigan At Ann Arbor · P01 · FY2019 · HL
Targeting the Tumor Vasculature to Treat Cancer
$2,219,678Steven K. Libutti · Clinical Sciences · Z01 · FY2007 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,219,566Barbara Burtness · Yale University · P50 · FY2022 · DE
Brain Tumor Therapeutic Efficacy by Quantitative MR
$2,219,379University Of Michigan At Ann Arbor · P01 · FY2003 · CA
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$2,219,336Jin Wang · Baylor College Of Medicine · U01 · FY2022 · AG
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$2,219,279Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Gene Therapy For Cystic Fibrosis Lung Disease
$2,219,200Paul B McCray · University Of Iowa · P01 · FY2016 · HL
Diverse Strategies to Correct the Dystrophin Gene Using Vascular Delivery (U54)
$2,219,184Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2007 · NS
Topiramate as a Disease Altering Therapy for CSPN
$2,219,043A Gordon Smith · Virginia Commonwealth University · U01 · FY2018 · NS
SPORE in Breast Cancer
$2,218,149Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2019 · CA
Molecular Diagnostics Core Laboratory
$2,218,020Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
The Molecular Biology Of The Mammalian Brain
$2,217,730Ronald D McKay · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS